Items where Subject is "32 BIOMEDICAL AND CLINICAL SCIENCES > 3211 Oncology and carcinogenesis > 321103 Cancer genetics"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0 [feed] RSS 2.0
Group by: Creators | Item Type
Jump to: A | B | D | E | F | H | L | M | S | V | Z
Number of items at this level: 14.

A

Al-Shinnag, Mohammad, Marfan, Helen, Susman, Rachel, Wakeling, Jan, Gustafson, Sonja, Wood, Simon, and Mallett, Andrew John (2021) Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes. Frontiers in Oncology, 11. 738822.

B

Bailey, Matthew H., Meyerson, William U., Dursi, Lewis Jonathan, Wang, Liang-Bo, Dong, Guanlan, Liang, Wen-Wei, Weerasinghe, Amilia, Li, Shantao, Li, Lize, Kelso, Sean, MC3 Working Group, , PCAWG novel somatic mutation calling methods working group, , Saksena, Gordon, Ellrott, Kyle, Wendl, Michael C., Wheeler, David A., Getz, Gad, Simpson, Jared T., Gerstein, Mark B., Ding, Li, and PCAWG Consortium, (2020) Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications, 11. 4748.

D

Dorney, Ryley, Dhungel, Bijay P., Rasko, John E.J., Hebbard, Lionel, and Schmitz, Ulf (2023) Recent Advances in Cancer Fusion Transcript Detection. Briefings in Bioinformatics, 24 (1). bbac519.

E

Emran, Abdullah Al, Nsengimana, Jérémie, Punnia-Moorthy, Gaya, Schmitz, Ulf, Gallagher, Stuart J., Newton-Bishop, Julia, Tiffen, Jessamy C., and Hersey, Peter (2020) Study of the female sex survival advantage in melanoma—a focus on x-linked epigenetic regulators and immune responses in two cohorts. Cancers, 12. 2082.

F

FitzGerald, Liesel M., Raspin, Kelsie, Marthick, James R., Field, Matt A., Malley, Roslyn C., Thomson, Russell J., Blackburn, Nicholas B., Banks, Annette, Charlesworth, Jac C., Donovan, Shaun, and Dickinson, Joanne L. (2017) Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours. Scientific Reports, 7. 17778.

H

Hayward, Nicholas K., Wilmott, James S., Waddell, Nicola, Johansson, Peter A., Field, Matthew A., Nones, Katia, Patch, Ann-Marie, Kakavand, Hojabr, Alexandrov, Ludmil B., Burke, Hazel, Jakrot, Valerie, Kazakoff, Stephen, Holmes, Oliver, Leonard, Conrad, Sabarinathan, Radhakrishnan, Mularoni, Loris, Wood, Scott, Xu, Qinying, Waddell, Nick, Tembe, Varsha, Pupo, Gulietta M., De Paoli-Iseppi, Ricardo, Vilain, Ricardo E., Shang, Ping, Lau, Loretta M.S., Dagg, Rebecca A., Schramm, Sarah-Jane, Pritchard, Antonia, Dutton-Regester, Ken, Newell, Felicity, Fitzgerald, Anna, Shang, Catherine A., Grimmond, Sean M., Pickett, Hilda A., Yang, Jean Y., Stretch, Jonathan R., Behren, Andreas, Kefford, Richard F., Hersey, Peter, Long, Georgina V., Cebon, Jonathan, Shackleton, Mark, Spillane, Andrew J., Saw, Robyn P.M., López-Bigas, Núria, Pearson, John V., Thompson, John F., Scolyer, Richard A., and Mann, Graham J. (2017) Whole-genome landscapes of major melanoma subtypes. Nature, 545. pp. 175-180.

L

Li, Constance H., Prokopec, Stephenie D., Sun, Ren X., Yousif, Fouad, Schmitz, Nathaniel, PCAWG Tumour Subtypes and Clinical Translation, , Boutros, Paul C., and PCAWG Consortium, (2020) Sex differences in oncogenic mutational processes. Nature Communications, 11. 4330.

M

Monteuuis, Geoffray, Schmitz, Ulf, Petrova, Veronika, Kearney, Padraic S., and Rasko, John E.J. (2020) Holding on to junk bonds: intron retention in cancer and therapy. Cancer Research, 81 (4). pp. 779-789.

Marshall, A.D., Bailey, C.G., Champ, K., Vellozzi, M., O'Young, P., Metierre, C., Feng, Y., Thoeng, A., Richards, A.M., Schmitz, U., Biro, M., Jayasinghe, R., Ding, L., Anderson, L., Mardis, E.R., and Rasko, J.E.J. (2017) CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic. Oncogene, 36. pp. 4100-4110.

S

Sathasivam, Hans P., Casement, John, Bates, Timothy, Sloan, Philip, Thomson, Peter, Robinson, Max, and Kist, Ralf (2021) Gene expression changes associated with malignant transformation of oral potentially malignant disorders. Journal of Oral Pathology and Medicine, 50 (1). pp. 60-67.

Sathasivam, Hans Prakash, Kist, Ralf, Sloan, Philip, Thomson, Peter, Nugent, Michael, Alexander, John, Haider, Syed, and Robinson, Max (2021) Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology. British Journal of Cancer, 125. pp. 413-421.

V

Vergara, Ismael A., Mintoff, Christopher P., Sandhu, Shahneen, McIntosh, Lachlan, Young, Richard J., Wong, Stephen, Colebatch, Andrew, Cameron, Daniel L., Kwon, Julia Lai, Wolfe, Rory, Peng, Angela, Ellul, Jason, Dou, Xuelin, Fedele, Clare, Boyle, Samantha, Arnau, Gisela Mir, Raleigh, Jeanette, Hatzimihalis, Athena, Szeto, Pacman, Mooi, Jennifer, Widmer, Daniel S., Cheng, Phil F., Amann, Valerie, Dummer, Reinhard, Hayward, Nicholas, Wilmott, James, Scolyer, Richard A., Cho, Raymond J., Bowtell, David, Thorne, Heather, Alsop, Kathryn, Cordner, Stephen, Woodford, Noel, Leditschke, Jodie, O’Brien, Patricia, Dawson, Sarah Jane, McArthur, Grant A., Mann, Graham J., Levesque, Mitchell P., Papenfuss, Anthony T., and Shackleton, Mark (2021) Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. Nature Communications, 12 (1). 1434.

Z

Zhang, Xiaomeng, Tang, Jian Zhong, Vergara, Ismael A., Zhang, Youfang, Szeto, Pacman, Yang, Lie, Mintoff, Christopher, Colebatch, Andrew, McIntosh, Lachlan, Mitchell, Katrina A., Shaw, Evangeline, Rizos, Helen, Long, Georgina V., Hayward, Nicholas, McArthur, Grant A., Papenfuss, Anthony T., Harvey, Kieran F,, and Shackleton, Mark (2019) Somatic hypermutation of the YAP oncogene in a human cutaneous melanoma. Molecular Cancer Research, 17 (7). pp. 1435-1449.

Zeng, Bijun, Middelberg, Anton P.J., Gemiarto, Adrian, Macdonald, Kelli, Baxter, Alan G., Talekar, Meghna, Moi, Davide, Tullett, Kirsteen M., Caminschi, Irina, Lahoud, Mireille H., Mazzieri, Roberta, Dolcetti, Riccardo, and Thomas, Ranjeny (2018) Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy. Journal of Clinical Investigation, 128 (5). pp. 1971-1984.

This list was generated on Wed Sep 20 22:37:59 2023 AEST.